Showing 1 - 5 results of 5 for search 'Rumiko Shimazawa', query time: 0.03s Refine Results
  1. 1
    Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus

    Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus by Masayuki Ikeda, Rumiko Shimazawa

    Published 2019-07-01
    Get full text
    Article
  2. 2
    Imbalance in glycemic control between the treatment and placebo groups in cardiovascular outcome trials in type 2 diabetes

    Imbalance in glycemic control between the treatment and placebo groups in cardiovascular outcome trials in type 2 diabetes by Rumiko Shimazawa, Masayuki Ikeda

    Published 2019-12-01
    Get full text
    Article
  3. 3
    Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)

    Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech) by Rumiko Shimazawa, Masayuki Ikeda

    Published 2021-12-01
    Get full text
    Article
  4. 4
    Approval status and evidence for WHO essential medicines for children in the United States, United Kingdom, and Japan: a cross-sectional study

    Approval status and evidence for WHO essential medicines for children in the United States, United Kingdom, and Japan: a cross-sectional study by Rumiko Shimazawa, Masayuki Ikeda

    Published 2017-12-01
    Get full text
    Article
  5. 5
    Repression of Activated Aryl Hydrocarbon Receptor–Induced Transcriptional Activation by 5α-Dihydrotestosterone in Human Prostate Cancer LNCaP and Human Breast Cancer T47D Cells

    Repression of Activated Aryl Hydrocarbon Receptor–Induced Transcriptional Activation by 5α-Dihydrotestosterone in Human Prostate Cancer LNCaP and Human Breast Cancer T47D Cells by Noriko Sanada, Yuka Gotoh, Rumiko Shimazawa, Carolyn M. Klinge, Ryoichi Kizu

    Published 2009-01-01
    Get full text
    Article

Search Tools: